 | • レポートコード：QY2207C3456 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の平衡透析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に平衡透析の世界市場のxxx％を占める「線形回帰」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「受託研究機関」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の平衡透析の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの平衡透析市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの平衡透析市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 平衡透析のグローバル主要メーカーには、Harvard Apparatus、Thermo Fisher Scientific、Aurora Borealis Control BV、The Nest Group、Cole-Parmer、Vivaproducts、Merck、3B Pharmaceuticals、ADMEcell、Eurofins Scientific、HT Dialysis、Creative Biolabs、Bioduro、Sekisui XenoTech、SDR Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 平衡透析市場は、種類と用途によって区分されます。世界の平衡透析市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 線形回帰、非線形回帰 【用途別セグメント】 受託研究機関、製薬＆バイオテクノロジー企業、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 平衡透析製品概要 - 種類別市場（線形回帰、非線形回帰） - 用途別市場（受託研究機関、製薬＆バイオテクノロジー企業、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の平衡透析販売量予測2017-2028 - 世界の平衡透析売上予測2017-2028 - 平衡透析の地域別販売量 - 平衡透析の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別平衡透析販売量 - 主要メーカー別平衡透析売上 - 主要メーカー別平衡透析価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（線形回帰、非線形回帰） - 平衡透析の種類別販売量 - 平衡透析の種類別売上 - 平衡透析の種類別価格 ・用途別市場規模（受託研究機関、製薬＆バイオテクノロジー企業、その他） - 平衡透析の用途別販売量 - 平衡透析の用途別売上 - 平衡透析の用途別価格 ・北米市場 - 北米の平衡透析市場規模（種類別、用途別） - 主要国別の平衡透析市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの平衡透析市場規模（種類別、用途別） - 主要国別の平衡透析市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の平衡透析市場規模（種類別、用途別） - 主要国別の平衡透析市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の平衡透析市場規模（種類別、用途別） - 主要国別の平衡透析市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの平衡透析市場規模（種類別、用途別） - 主要国別の平衡透析市場規模（トルコ、サウジアラビア） ・企業情報 Harvard Apparatus、Thermo Fisher Scientific、Aurora Borealis Control BV、The Nest Group、Cole-Parmer、Vivaproducts、Merck、3B Pharmaceuticals、ADMEcell、Eurofins Scientific、HT Dialysis、Creative Biolabs、Bioduro、Sekisui XenoTech、SDR Scientific ・産業チェーン及び販売チャネル分析 - 平衡透析の産業チェーン分析 - 平衡透析の原材料 - 平衡透析の生産プロセス - 平衡透析の販売及びマーケティング - 平衡透析の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 平衡透析の産業動向 - 平衡透析のマーケットドライバー - 平衡透析の課題 - 平衡透析の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Equilibrium Dialysis Market
The global Equilibrium Dialysis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Linear Regression accounting for % of the Equilibrium Dialysis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Contract Research Organizations segment is altered to an % CAGR throughout this forecast period.
China Equilibrium Dialysis market size is valued at US$ million in 2021, while the North America and Europe Equilibrium Dialysis are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Equilibrium Dialysis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Equilibrium Dialysis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Equilibrium Dialysis market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Equilibrium Dialysis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Equilibrium Dialysis market.
Global Equilibrium Dialysis Scope and Market Size
Equilibrium Dialysis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Equilibrium Dialysis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Linear Regression
Non-Linear Regression
Segment by Application
Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Others
By Company
Harvard Apparatus
Thermo Fisher Scientific
Aurora Borealis Control BV
The Nest Group
Cole-Parmer
Vivaproducts
Merck
3B Pharmaceuticals
ADMEcell
Eurofins Scientific
HT Dialysis
Creative Biolabs
Bioduro
Sekisui XenoTech
SDR Scientific
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Equilibrium Dialysis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Linear Regression
1.2.3 Non-Linear Regression
1.3 Market by Application
1.3.1 Global Equilibrium Dialysis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Contract Research Organizations
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Equilibrium Dialysis Market Perspective (2017-2028)
2.2 Equilibrium Dialysis Growth Trends by Region
2.2.1 Equilibrium Dialysis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Equilibrium Dialysis Historic Market Size by Region (2017-2022)
2.2.3 Equilibrium Dialysis Forecasted Market Size by Region (2023-2028)
2.3 Equilibrium Dialysis Market Dynamics
2.3.1 Equilibrium Dialysis Industry Trends
2.3.2 Equilibrium Dialysis Market Drivers
2.3.3 Equilibrium Dialysis Market Challenges
2.3.4 Equilibrium Dialysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Equilibrium Dialysis Players by Revenue
3.1.1 Global Top Equilibrium Dialysis Players by Revenue (2017-2022)
3.1.2 Global Equilibrium Dialysis Revenue Market Share by Players (2017-2022)
3.2 Global Equilibrium Dialysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Equilibrium Dialysis Revenue
3.4 Global Equilibrium Dialysis Market Concentration Ratio
3.4.1 Global Equilibrium Dialysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Equilibrium Dialysis Revenue in 2021
3.5 Equilibrium Dialysis Key Players Head office and Area Served
3.6 Key Players Equilibrium Dialysis Product Solution and Service
3.7 Date of Enter into Equilibrium Dialysis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Equilibrium Dialysis Breakdown Data by Type
4.1 Global Equilibrium Dialysis Historic Market Size by Type (2017-2022)
4.2 Global Equilibrium Dialysis Forecasted Market Size by Type (2023-2028)
5 Equilibrium Dialysis Breakdown Data by Application
5.1 Global Equilibrium Dialysis Historic Market Size by Application (2017-2022)
5.2 Global Equilibrium Dialysis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Equilibrium Dialysis Market Size (2017-2028)
6.2 North America Equilibrium Dialysis Market Size by Type
6.2.1 North America Equilibrium Dialysis Market Size by Type (2017-2022)
6.2.2 North America Equilibrium Dialysis Market Size by Type (2023-2028)
6.2.3 North America Equilibrium Dialysis Market Share by Type (2017-2028)
6.3 North America Equilibrium Dialysis Market Size by Application
6.3.1 North America Equilibrium Dialysis Market Size by Application (2017-2022)
6.3.2 North America Equilibrium Dialysis Market Size by Application (2023-2028)
6.3.3 North America Equilibrium Dialysis Market Share by Application (2017-2028)
6.4 North America Equilibrium Dialysis Market Size by Country
6.4.1 North America Equilibrium Dialysis Market Size by Country (2017-2022)
6.4.2 North America Equilibrium Dialysis Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Equilibrium Dialysis Market Size (2017-2028)
7.2 Europe Equilibrium Dialysis Market Size by Type
7.2.1 Europe Equilibrium Dialysis Market Size by Type (2017-2022)
7.2.2 Europe Equilibrium Dialysis Market Size by Type (2023-2028)
7.2.3 Europe Equilibrium Dialysis Market Share by Type (2017-2028)
7.3 Europe Equilibrium Dialysis Market Size by Application
7.3.1 Europe Equilibrium Dialysis Market Size by Application (2017-2022)
7.3.2 Europe Equilibrium Dialysis Market Size by Application (2023-2028)
7.3.3 Europe Equilibrium Dialysis Market Share by Application (2017-2028)
7.4 Europe Equilibrium Dialysis Market Size by Country
7.4.1 Europe Equilibrium Dialysis Market Size by Country (2017-2022)
7.4.2 Europe Equilibrium Dialysis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Equilibrium Dialysis Market Size (2017-2028)
8.2 Asia-Pacific Equilibrium Dialysis Market Size by Type
8.2.1 Asia-Pacific Equilibrium Dialysis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Equilibrium Dialysis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Equilibrium Dialysis Market Share by Type (2017-2028)
8.3 Asia-Pacific Equilibrium Dialysis Market Size by Application
8.3.1 Asia-Pacific Equilibrium Dialysis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Equilibrium Dialysis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Equilibrium Dialysis Market Share by Application (2017-2028)
8.4 Asia-Pacific Equilibrium Dialysis Market Size by Region
8.4.1 Asia-Pacific Equilibrium Dialysis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Equilibrium Dialysis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Equilibrium Dialysis Market Size (2017-2028)
9.2 Latin America Equilibrium Dialysis Market Size by Type
9.2.1 Latin America Equilibrium Dialysis Market Size by Type (2017-2022)
9.2.2 Latin America Equilibrium Dialysis Market Size by Type (2023-2028)
9.2.3 Latin America Equilibrium Dialysis Market Share by Type (2017-2028)
9.3 Latin America Equilibrium Dialysis Market Size by Application
9.3.1 Latin America Equilibrium Dialysis Market Size by Application (2017-2022)
9.3.2 Latin America Equilibrium Dialysis Market Size by Application (2023-2028)
9.3.3 Latin America Equilibrium Dialysis Market Share by Application (2017-2028)
9.4 Latin America Equilibrium Dialysis Market Size by Country
9.4.1 Latin America Equilibrium Dialysis Market Size by Country (2017-2022)
9.4.2 Latin America Equilibrium Dialysis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Equilibrium Dialysis Market Size (2017-2028)
10.2 Middle East & Africa Equilibrium Dialysis Market Size by Type
10.2.1 Middle East & Africa Equilibrium Dialysis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Equilibrium Dialysis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Equilibrium Dialysis Market Share by Type (2017-2028)
10.3 Middle East & Africa Equilibrium Dialysis Market Size by Application
10.3.1 Middle East & Africa Equilibrium Dialysis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Equilibrium Dialysis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Equilibrium Dialysis Market Share by Application (2017-2028)
10.4 Middle East & Africa Equilibrium Dialysis Market Size by Country
10.4.1 Middle East & Africa Equilibrium Dialysis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Equilibrium Dialysis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Harvard Apparatus
11.1.1 Harvard Apparatus Company Details
11.1.2 Harvard Apparatus Business Overview
11.1.3 Harvard Apparatus Equilibrium Dialysis Introduction
11.1.4 Harvard Apparatus Revenue in Equilibrium Dialysis Business (2017-2022)
11.1.5 Harvard Apparatus Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Equilibrium Dialysis Introduction
11.2.4 Thermo Fisher Scientific Revenue in Equilibrium Dialysis Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Aurora Borealis Control BV
11.3.1 Aurora Borealis Control BV Company Details
11.3.2 Aurora Borealis Control BV Business Overview
11.3.3 Aurora Borealis Control BV Equilibrium Dialysis Introduction
11.3.4 Aurora Borealis Control BV Revenue in Equilibrium Dialysis Business (2017-2022)
11.3.5 Aurora Borealis Control BV Recent Developments
11.4 The Nest Group
11.4.1 The Nest Group Company Details
11.4.2 The Nest Group Business Overview
11.4.3 The Nest Group Equilibrium Dialysis Introduction
11.4.4 The Nest Group Revenue in Equilibrium Dialysis Business (2017-2022)
11.4.5 The Nest Group Recent Developments
11.5 Cole-Parmer
11.5.1 Cole-Parmer Company Details
11.5.2 Cole-Parmer Business Overview
11.5.3 Cole-Parmer Equilibrium Dialysis Introduction
11.5.4 Cole-Parmer Revenue in Equilibrium Dialysis Business (2017-2022)
11.5.5 Cole-Parmer Recent Developments
11.6 Vivaproducts
11.6.1 Vivaproducts Company Details
11.6.2 Vivaproducts Business Overview
11.6.3 Vivaproducts Equilibrium Dialysis Introduction
11.6.4 Vivaproducts Revenue in Equilibrium Dialysis Business (2017-2022)
11.6.5 Vivaproducts Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Equilibrium Dialysis Introduction
11.7.4 Merck Revenue in Equilibrium Dialysis Business (2017-2022)
11.7.5 Merck Recent Developments
11.8 3B Pharmaceuticals
11.8.1 3B Pharmaceuticals Company Details
11.8.2 3B Pharmaceuticals Business Overview
11.8.3 3B Pharmaceuticals Equilibrium Dialysis Introduction
11.8.4 3B Pharmaceuticals Revenue in Equilibrium Dialysis Business (2017-2022)
11.8.5 3B Pharmaceuticals Recent Developments
11.9 ADMEcell
11.9.1 ADMEcell Company Details
11.9.2 ADMEcell Business Overview
11.9.3 ADMEcell Equilibrium Dialysis Introduction
11.9.4 ADMEcell Revenue in Equilibrium Dialysis Business (2017-2022)
11.9.5 ADMEcell Recent Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Equilibrium Dialysis Introduction
11.10.4 Eurofins Scientific Revenue in Equilibrium Dialysis Business (2017-2022)
11.10.5 Eurofins Scientific Recent Developments
11.11 HT Dialysis
11.11.1 HT Dialysis Company Details
11.11.2 HT Dialysis Business Overview
11.11.3 HT Dialysis Equilibrium Dialysis Introduction
11.11.4 HT Dialysis Revenue in Equilibrium Dialysis Business (2017-2022)
11.11.5 HT Dialysis Recent Developments
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Equilibrium Dialysis Introduction
11.12.4 Creative Biolabs Revenue in Equilibrium Dialysis Business (2017-2022)
11.12.5 Creative Biolabs Recent Developments
11.13 Bioduro
11.13.1 Bioduro Company Details
11.13.2 Bioduro Business Overview
11.13.3 Bioduro Equilibrium Dialysis Introduction
11.13.4 Bioduro Revenue in Equilibrium Dialysis Business (2017-2022)
11.13.5 Bioduro Recent Developments
11.14 Sekisui XenoTech
11.14.1 Sekisui XenoTech Company Details
11.14.2 Sekisui XenoTech Business Overview
11.14.3 Sekisui XenoTech Equilibrium Dialysis Introduction
11.14.4 Sekisui XenoTech Revenue in Equilibrium Dialysis Business (2017-2022)
11.14.5 Sekisui XenoTech Recent Developments
11.15 SDR Scientific
11.15.1 SDR Scientific Company Details
11.15.2 SDR Scientific Business Overview
11.15.3 SDR Scientific Equilibrium Dialysis Introduction
11.15.4 SDR Scientific Revenue in Equilibrium Dialysis Business (2017-2022)
11.15.5 SDR Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer